تحليل الجدوى المالية للشركات المدرجة في البورصة الجزائرية باستخدام مؤشرات التدفق النقدي

الملخص EN

This research aimed to demonstrate the power of the statement of cash flow in assessing the financial viability of firms listed on the Algerian stock exchange, using fundamental cash flow indicators in the areas of liquidity, solvency and quality of sales.

NCA Rouiba, and Biopharm group were selected to test the research hypothesis between the periods of 2016-2018.

.

According to the results, firms are low quality of income and unable to meet their debt over the years of the study, because they are not good enough to generate sufficient operating cash flow due too much losses realised or working capital requirement(WCR) increased.

Key words: Financial viability analysis; Cash flow statement; Cash flow indicators; NCA Rouiba; Biopharm SPA group.

JEL classification codes: M40, G31, C61.